Subscribe

0

  • Sign in with Email

By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.

Don’t have an account? Signup

  • Bookmarks
  • My Profile
  • Log Out
  • NEWS
  • POLICIES
  • MSME OPPORTUNITIES
  • BANKING & FINANCE
  • TECHNOLOGY FOR SMES
  • SECTORS
  • GLOBAL
  • Investment
  • LEGAL
  • KNOWLEDGE QUEST
  • Future Ready Forum 2025
  • Ek Nayi Udaan
  • Future Ready Summit 2024
  • ADVERTISE WITH US
ad_close_btn
  • News
  • Policies
  • Banking & Finance
  • MSME Opportunities
  • Web Stories
  • InFocus
  • Technology For SMEs
  • Sectors
  • Global
  • Fashion

Powered by :

You have successfully subscribed the newsletter.

CIPLA

YUSUF HAMIED, CIPLA Sectors

Cipla to Increase Stake in GoApptiv to 22%

Pharmaceutical company Cipla will acquire an additional stake worth Rs 25.90 crore in digital tech company GoApptiv, thus increasing its stake in the latter to 22.02 per cent, it said in a regulatory filing to the stock exchanges.

By SMEStreet Edit Desk
logoJun 28, 2022 06:16 IST logo 1 Min read
Remdesivir Injection, News
Remdesivir Injection's Price Reduced, Here are the New Prices
By SMEStreet Edit Desk
logoApr 19, 2021 05:42 IST logo 1 Min read
YUSUF HAMIED, CIPLA News
Cipla Gets Final Approval for Generic Version of GlaxoSmithKline's IMITREX
By SMEStreet Edit Desk
logoMar 02, 2021 09:39 IST logo 1 Min read
Shekhar Mande, CSIR News
Cost Effective Process Technology of Favipiravir Developed by CSIR Used by M/s Cipla Ltd.
By SMEStreet Edit Desk
logoJul 24, 2020 11:00 IST logo 1 Min read
YUSUF HAMIED, CIPLA Sectors
Cipla to Acquire Stakes in GoApptiv of Rs 9 Crore
By SMEStreet Desk
logoJun 10, 2020 05:52 IST logo 1 Min read
YUSUF HAMIED, CIPLA Sectors
Cipla Signed Licensing Pact with Gilead to Manufacture & Distribute Remdesivir
By SMEStreet Desk
logoMay 13, 2020 07:01 IST logo 2 Min read
newsletter image
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news
Latest Stories
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news

Latest Stories
Latest Stories
    Powered by


    Subscribe to our Newsletter!




    Powered by
    Select Language
    English

    Share this article

    If you liked this article share it with your friends.
    they will thank you later

    Facebook
    Twitter
    Whatsapp

    Copied!